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Summary 
We have established a model system for analyzing the 
induction of self-tolerance among mature peripheral 
T cells in V85 TCR Tg mice. Both CDS+VpS+ and 
CDS+VpS+ cells undergo a superantigendrfven chronic 
deletion in the periphery of I-E- mice. Prior to their 
disappearance, CD4+ transgene-expressing cells are 
activated and then rendered anergic to further stimula- 
tion through their TCRs. This scenario differs strikingly 
in the CD8+ cellular compartment, which is character- 
ized by a distinct Population of CD8’Yr85’” cells local- 
ized to the blood and spleen. CD8’O cells are small, 
express the surface phenotype of memory cells, and 
rapidly incorporate BrdU in vivo. The kinetics of their 
appearance and disappearance in adult thymecto- 
mized mice, the rapid chasing of BrdU from labeled 
cells, and their in vivo cortisone sensitivity all suggest 
CD8’” cells are slated for deletion. Furthermore, their 
functional incompetence can be documented in vitro 
in the absence of internucleosomal DNA fragmenta- 
tion. Thus, we have identified an intermediate popula- 
tion of T cells targeted for peripheral deletion that, 
although functionally compromised, has not yet un- 
dergone programmed cell death. 
Introduction 
One of the key challenges of the immune system is the 
induction and maintenance of self-tolerance, a process 
that requires the systematic sorting of lymphocyte clones 
to target those that are potentially autoreactive. Although 
most self-reactive T cells are clonally deleted within the 
thymus in a process known as negative selection, a sec- 
ond tierof mechanismsoperatesin the lymphoid periphery 
to reduce further the risk of autoimmunity. Induction of 
peripheral tolerance is essential to contend with the few 
immunocompetent autoreactive cells that escape intra- 
thymic deletion and with those cells that recognize tissue- 
specific or developmentally regulated self-antigens that 
are not sampled during thymic education. Experimental 
evidence has defined several mechanisms for inducing 
tolerance in the lymphoid periphery, including clonal igno- 
rance or indifference to the antigen (reviewed by Miller 
and Heath, 1993) extrathymic clonal deletion (Webb et 
al., 1990; Huang and Crispe, 1993), clonal anergy or unre- 
sponsiveness (Rammensee et al., 1989; Burkly et al., 
1989; Blackman et al., 1990; Hewitt et al., 1992) and 
down-regulation of the T cell receptor (TCR), accessory 
molecules, or both on autoaggressive cells (Rocha and 
von Boehmer, 1991; Schijnrich et al., 1991; Schijnrich et 
al., 1992; Rocha et al., 1995). These mechanisms are not 
necessarily mutually exclusive, and in many casesoperate 
in concert. 
Analyses of the mechanisms operating to ensure self- 
tolerance have made use of two principal tools: lines of 
TCR transgenic (Tg) mice engineered to limit the diversity 
of expressed TCRs, and a category of antigens called su- 
perantigens (SAgs) that associate with major histocompat- 
ibility complex (MHC) class II molecules outside the pep- 
tide-binding groove and interact with the TCR largely 
through the VP region (reviewed by Kotzin et al., 1993). 
This latter property of SAgs has enabled immunologists to 
follow SAg-reactive populations of heterogeneous T cells 
using anti-V5 antibodies. One well-studied group of SAgs 
are those encoded by an open reading frame in the 3’ 
long terminal repeat of exogenous or endogenous mouse 
mammary tumor viruses (Mtv) (reviewed by Held et al., 
1994). 
We have studied the induction of tolerance among ma- 
ture peripheral T cells in a model system using C57BU6 
(B6) mice transgenic for a V65.2’ TCRP chain gene. In 
these animals, the TCRa chain repertoire is diverse, being 
encoded by rearranged endogenous a chain genes (Dillon 
et al., 1994). Expression of V65 in normal mice is atypical 
in that it is skewed toward the CD8’ compartment of T 
cells (10%-l 2% of CD8+ peripheral T cells are V55.1+ or 
V85.2+ in an adult B6 mouse, compared with only 30/o- 
5% of CD4’cells) (Liao et al., 1990; Bill et al., 1990). Fur- 
thermore, both CD4’ and CD8’ T cells that express Vp5+ 
TCR are deleted intrathymically in l-E+ mice that express 
a SAg encoded by the endogenous retrovirus Mtv-9 
(Woodland et al., 1990, 1991a, 1991b). lntrathymic dele- 
tion of Vj35’ T cells does not occur in I-E- strains of mice 
such as B6, but in VP5 Tg B6 mice, transgene-expressing 
CD4’cells are chronically selected against in the lymphoid 
periphery (Fink et al., 1992). Prior to their deletion, 
CD4+Vj35+ cells are activated and rendered anergic to sig- 
nals through their TCRs (Fink et al., 1994). These data 
support the concept that activation of T cells somehow 
enhances their susceptibility to cell death (Webb et al., 
1990), and that the down-regulation of the expression of 
“anti-death” genes such as bcl-2 can promote the process 
of apoptosis (reviewed by Akbar et al., 1993; Oltvai and 
Korsmeyer, 1994; Nufiez et al., 1994). It is becoming in- 
creasingly clear that cell death is a frequent endpoint of 
vigorous immune responses, including those directed 
against self-antigens. 
We now show that the induction of tolerance to endoge- 
nous SAgs in the lymphoid periphery can continuously 
modulate the TCR repertoire, even in the absenceof signif- 
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Figure 1. The Slow and Incomplete Deletion of CDS+Vf35+ and 
CD4+V85+ Cells in the Periphery of I-E- V85 Tg Mice Is Accompanied 
by the Loss of T Cells and the Appearance of a Distinct Population 
of CD8” Cells 
(A) PBLs isolated from individual Vf35 Tg mice were stained with anti- 
V55-fluorescein isothiocyanate (FITC) and anti-CD4-phycoerythrin 
(PE) or anti-CDBa-PE MAbs and analyzed by flow cytometry. The 
percent of V55expressing cells in the CD4+ (open squares) and CD8’ 
(closed squares) subsets was determined by gating electronically on 
PE’ populations and plotted as a function of the age of the donor 
animal. 
(6) Comparison between the percent of total T cells (the percent of 
CD4’ plus the percent of CD8+) in PBL from nonTg (stippled bars) and 
VP5 Tg (shaded bars) mice of the indicated ages. Error bars represent 
the SD from the mean of the observed values from 3-27 mice per 
group. PBLs from 5-85 week old mice were stained as in (A). 
(C) The percent of CD8Wotal CD8’ cells (closed circles) is plotted 
alongside the percent of total T cells (open circles) in Vf35 Tg mice of 
the indicated ages, including data collected from splenocytes pooled 
from 4-day-old pups. The percent of CD8’” cells is plotted in this manner 
to correct for the age-related decline in the absolute numbers of CD8’ 
cells in the Tg mice. Error bars represent the SD from the mean of 
data obtained from 3-l 1 mice at each timepoint. Points lacking error 
bars correspond to data obtained from l-2 mice. 
icant thymic output. We demonstrate a phenotypically dis- 
tinct intermediate in a deletional pathway within the popu- 
lation of V85+CD8+ cells that distinguishes self-tolerance 
induction among CD8’ T cells from that induced among 
CD4’ cells. 
Results 
CD4+Vfl5+ and CDS+VpS+ Cells are Eliminated 
in the Periphery of VP5 Tg Mice 
Previously, we studied tolerance among peripheral CD4+ 
T cells in 68 mice that are transgenic for a rearranged 
gene encoding a Vf35+ TCR6 chain (Fink et al., 1992). In 
an effort to identify the V85-specific tolerogen in our sys- 
tem, we have crossed these B8 Vf35 Tg mice with an H-2b 
recombinant inbred strain derived from B8 and DBA/2 
mice, designated BXD15 (Fink et al., 1994). Surprisingly, 
analyses of peripheral blood lymphocytes (PBLs) from the 
(BGxBXD15)Fl Tg mice demonstrate that both CD4+ and 
CD8’ cell compartments are characterized by an age- 
dependent decline in cells bearing the V85+ transgene 
(Figure 1A). This decline occurs in the lymphoid periphery 
and results in the emergence of TCRa8’ cells bearing 
endogenous TCR8 chains and not the transgene-encoded 
V85’ 8 chain, particularly within the CD4+ compartment 
(data not shown). This selective depletion severely re- 
duces the numbers of peripheral T cells in Fl VP5 Tg 
mice by the time they reach middle age (25-40 weeks). 
Strikingly, this T cell loss is significantly greater than the 
age-related decline in T cells in nontransgenic (nonTg) 
littermates (Figure 1 B). This depletion contrasts with that 
documented in the parental line of 86 Vp5 Tg, in which the 
loss of transgene-expressing cells is primarily restricted to 
the CD4+ subset and is less rapid and severe than that 
observed in the Fl mice (compare Figures 1A and 1 B to 
Fink et al., 1992). To analyze the basis for the depletion 
of transgene-expressing CD8’ cells, (B6xBXD15)Fl Vp5 
Tg mice were used in all experiments described here and, 
for simplicity, will be referred to subsequently as Vp5 Tg. 
CD8’O Cells in VP5 Tg Mice 
Interestingly, the decline in peripheral T cell number in the 
V85 Tg mice coincides with the appearance of a distinct 
population of cells with reduced surface levelsof CD8 mol- 
ecules (Figure 1C). The proportion of these CD8r” cells 
generally increases as the number of total peripheral T 
cells decreases, but with considerable variation among 
young to middle-aged mice both in the timing of the ap- 
pearance of CD8r0 cells and in the extent to which they 
dominate the CD8 compartment (Figure 1C). The appear- 
ance of the CD8” population correlates with the timing of 
the decline in the percent of CD8+ cells expressing V85 
(Figures 1A and 1C). Furthermore, this CD8’O population 
is cleanly separated from CD8”’ lymphocytes in blood, less 
well separated but clearly present among splenocytes, 
and absent in both peripheral and mesenteric lymph nodes 
from the VP5 Tg mice (Figure 2; data not shown). This 
organ preference can be explained by an altered pattern 
of recirculation (see below). In contrast, an analogous pop- 
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Figure 2. There Is a Distinct Peak of CD8’ Cells in the Blood and 
Spleen, but Not in the Lymph Nodes, of 435 Tg Mice 
PBLs. splenocytes, and lymph node cells from 19week-old V55 Tg 
and littermate nonTg mice were stained with anti-CD8a-PE MAb and 
analyzed by flow cytometry. The CD8 profiles are shown for nonTg 
PBLs (top) and Vf35 Tg PBLs, splenocytes, and lymph node cells 
pooled from peripheral and mesenteric nodes. Lymph node cells ana- 
lyzed separately from peripheral and mesenteric nodes were indistin- 
guishable from the pool (data not shown). The CD8 staining is on a 
logarithmic scale; numbers on the vertical axis correspond to the rela- 
tive number of cells in each channel. The CD8” subset among Tg PBL 
and splenocytes is indicated with an arrow. 
ulation of CD4’” cells was not observed in VP5 Tg mice at 
any time (data not shown). 
CD8’O Cells Exhibit Signs of Prior Activation 
Detailed characterization of the surface phenotype of 
CD8’” cells revealed that relative to CD8”’ cells, they also 
express low levels of V65, CD3s, and Thy-l (Figure 3), 
and are also low for CD5 and CD28 (data not shown). The 
decrease in the level of staining with anti-CD8 and anti-V55 
antibodiesisnot areagent-specificeffect, sinceCD810cells 
stain at low levels with an anti-CD88 monoclonal antibody 
(MAb), with two different antiCD8a reagents, directly con- 
jugated or in a “sandwich” with fluorochrome-conjugated 
second stage reagents, and with the anti-TCR5 MAb H57- 
597 (data not shown). Furthermore, CD8’O cells express 
normal levels of H-2Kb and CD2 (Figure 3) emphasizing 
the specificity of the down-regulation of CD8, TCR, Thy-l, 
CD5, and CD28 expression. CD8’” cells do not express 
8220, HSA, or NKl .l (data not shown). CD8W85” cells 
express uniformly high levels of the memory cell marker 
CD44, while the more conventional CD8hiTCRhi population 
within the same animal expresses heterogeneous levels, 
ranging from low to high (Figure 3). CD8’” cells are also 
enriched for CD1 1 ahi, CD45RBr”, CD49dhi, CD54hi, and 
CD62L- cells (Figure 3), confirming their prior activation. 
Furthermore, CD8r0 cells behave as activated cells in vivo 
in at least one key property, their absence in uninflamed 
lymph nodes (see Figure 2). Cells with such an activated 
surface phenotype inefficiently enter lymph nodes from 
the blood through high endothelial venules (Mackay, 
1991). 
Despite the expression of multiple activation markers, 
the CD8’” population is not enriched for blasts; indeed, 
their forward light scatter profiles indicate they are slightly 
smaller than CD8”‘cells (Figure 3). They are also negative 
for expression of the early activation marker CD89 and 
for CD25, the interleukin-2Ra (IL-2Ra) chain (data not 
shown). Thus, the phenotype of CD6’” cells defines them 
as a distinct subpopulation of previously activated periph- 
eral T cells. 
CD8’” Cells Constitute an Unstable Compartment 
and Are Slated for Deletion 
The generation and lifespan of CD8” cells can be studied 
in thymectomized young adult Tg mice. In these animals, 
the proportion of CD8’” cells peaks at about 13 weeks post- 
thymectomy, and then steadily declines to less than pre- 
thymectomy levels (Figure 4A). This 3 month timeframe 
suggests that the signal to down-regulate CD6 expression 
is delivered in the periphery. The percent of total CD8+ T 
cells among PBLs reaches a minimum of approximately 
4% (Figure 48) as the representation of CD8” cells peaks, 
at 13 weeks after thymectomy (Figure 4A). The gradual 
increase after this timepoint in both the percent of CD8+ 
cells and the percent of total T cells (the sum of CD4+ and 
CD6+ cells) may be due to proliferation of the remaining 
CD8”’ cells, although the reexpression of high levels of CD8 
by the CD8’” population is also a formal possibility. 
Note that the percent of total T cells approximates the 
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percent of CD8+ cells (Figure 48) due to the rapid loss 
of CD4+V85+cellsafterthymectomy(Finket al., 1992;data 
not shown). These data are compatible with the generation 
from the CDBhi compartment of a wave of CD8’” cells that 
then disappear, leaving behind a depleted population of 
CD8hi cells from which additional CD8’” cells cannot be 
generated. 
It has been previously shown that the peripheral deletion 
of SAg-reactive T cells is enhanced by injection of hydro- 
cortisone (Lussow et al., 1993). As shown in Figure 5, 
the CD8r0Vf3P cells are clearly more sensitive to in vivo 
cortisone treatment than are the CDBhiVtXhi cells (compare 
box 1 with box 2). Thus, the data in Figures 3-5 strongly 
suggest that the CD8’” compartment consists of previously 
stimulated cells that are targeted for deletion. 
To examine more directly the in vivo proliferative capac- 
ity of CD8’” cells and their progenitors, we followed the 
uptake and loss of the nonreutilizable thymidine analog 
bromodeoxyuridine (BrdU). NonTg and Vf35 Tg mice were 
administered BrdU in their drinking water for 8 days and 
incorporation of this label into each cellular subset was 
assessed by flow cytometric analysis of permeabilized 
cells stained with an anti-BrdU MAb (Tough and Sprent, 
1994). As shown in Figure 6A, 52% of CD8r0cells are BrdU’ 
after an 8 day pulse, compared with only 22% of CD8hi 
Figure 3. CD8’ Cells Express Low Levels of 
Several Other Surface Markers and Show 
Signs of Prior Activation 
PBLs or splenocytes from 14- to PI-week-old 
Vf35 Tg mice were analyzed by flow cytometry 
after staining with anti-CDBa-PE and FITC- 
conjugated anti-V85, Thy-l .2, CD45RB, or 
CD54 (ICAM-1) MAbs, anti-H-2Kb MAb followed 
by FITC-conjugated goat anti-mouse IgG Fc, 
anti-CDlla (LFA-1) MAb followed by FITC- 
conjugated goat anti-rat IgG, or biotinylated 
antXD2, anti-CDBs, anti-CD44 (Pgp-1). anti- 
CD49d (VLA-f), or antiCD62L (L-selectin) 
MAbs followed by FITC- or tricolor-conjugated 
streptavidin. Forward scatter is plotted on a lin- 
ear scale; all other axes are logarithmic. 
cells from the same Tg animal. Even fewer CDBhi cells 
(9%) are labeled in a nonTg littermate (Figure 6A), and the 
extent of labeling in this compartment is relatively invariant 
over the course of a 3 week chase (Figure 6B). In contrast, 
the BrdU content in the Tg CD8” compartment steadily 
declines over this time period (Figure 6B). The rapid up 
take and loss of BrdU within the CD8’” subpopulation indi- 
cates the instability of this cellular compartment, reinforc- 
ing their identification as intermediates in a deletional 
process. 
CD8’” Cells Are Functionally Compromised 
Given that the CD8” cells express activation markers and 
appear to be on a pathway to deletion, we performed a 
series of assays to determine their functional competence. 
Using FACS-sorted cells in a limiting dilution assay de- 
signed to detect all cytotoxic T lymphocyte precursors 
(CTLp) regardless of TCR specificity (Bevan and Cohn, 
1975; Wilson et al., 1982) we found that the CD8’” cells 
are 73-fold reduced in total CTLp relative to their CD8”’ 
counterparts (Figure 7A). A 7. to 25-fold reduction among 
CD8’O cells from naive mice in CTLp specific for conven- 
tional antigen (OVA+ H-2Kb, Dillon et al., 1994) or alloanti- 
gen (H-P) was also observed (data not shown). 
In addition, CD81° cells proliferate poorly to signals deliv- 
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Figure 4. The Percent of CDB’ Cells in Adult Thymectomized Vb5 Tg 
Mice Peaks at 13 Weeks after Surgery 
Tg mice were thymectomized at 12.5 weeks of age, were housed in 
two separate cages, and remained healthy throughout the course of 
the experiment, PBLs isolated at the indicated timepoints after surgery 
were stained with antiCD4, anti-Vf35, and antiCD8a MAbs to assess 
the relative percent of CDBb and CD@ ceils and the total percent of 
T cells. 
(A) Each curve represents the timecourse of an individual mouse, 
separately denoted by the open circles, squares, and triangles. 
(B) The mean values plus or minus the SD are plotted for the 3 mice 
at each timepoint of the percent of CD8+ cells (closed circles, solid 
line), calculated as percent of CDB”’ plus percent of CD@‘, and the 
percent of total T cells (Xs, dotted line), calculated as percent of CD4’ 
plus percent of CD8+ cells. 
ered through the TCR-CD3 complex, a defect only par- 
tially overcome by the addition of exogenous IL-2 (Figure 
76). Even bypassing the TCR with phorbol myristate ace- 
tate (PMA) plus ionomycin did not fully restore the growth 
capacity of the CD8r0 cells. This implies that the CD8’” cells 
harbor a defect in signaling downstream of that previously 
described for anergic cells (Bhandoola et al., 1993) or 
that they have an increased tendency to die in vitro, even 
in the presence of IL-2 (see below). 
To pursue further the possibility that CD81° cells possess 
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Figure 5. CD@ Cells Are Sensitive to Hydrocortisone In Vivo 
Splenocytes from uninjected I l-week-old V!35 Tg control mice (top) 
and Tg littermates injected intraperitoneally 2 days previously with 
hydrocortisone acetate (bottom) were stained with anti-VP5-FITC and 
anti-CD&-PE MAbs and analyzed by flow cytometry. The disappear- 
ance of CD8” cells was also apparent by counterstaining with MAbs 
specific for Thy-l, CD44, or CD49d. Similar results were also obtained 
with PBL in three separate experiments, using a total of 9 injected Tg 
mice at 12-29 weeks of age. 
defective signaling machinery, we quantitated the re- 
sponse of CD8’” and CDBhi cells to signals through the 
TCR-CD3 complex. As shown in Figure 7C, CD8r0 cells 
have a reduced capacity to mobilize calcium in response 
to stimulation with the anti-CD3s MAb 1452Cll. It is not 
yet possible to distinguish clearly whether this observation 
reflects a signaling defect in the CDE’” cells or is the result 
of reduced numbers of surface TCR-CD3 complexes (see 
Discussion). Arguing against this latter interpretation are 
the identical kineticsof the responses by both CD8 subsets 
and the fact that 4-fold higher concentrations of stimula- 
tory antibody do not restore the CD8r0 response (data not 
shown). 
CD8’” Cells Are Poised to Die 
Given their immunoincompetence, we next asked whether 
CD8r” cells might be prone to undergo programmed cell 
death. As shown in Figure 8 (top), relative to their CD8”’ 
counterparts, CD8” cells express reduced levels of the 
intermitochondrial membrane-associated protein Bcl-2. 
Results from four separate experiments with PBL or splen- 
ocytes from mice 17-31 weeks of age indicate that the 
difference in Bcl-2 expression between CDBhi and CD8r0 
cells is more striking in PBL than in spleen, and more 
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Figure 6. CD8’” Cells Proliferate or Are Derived from a Proliferative 
Compartment 
(A) CDBM cells label extensively with BrdU administered in vivo. NonTg 
and Vf35 Tg mice were thymectomized at 10 weeks of age, allowed 
to recover for 2 weeks, and then placed on BrdU water for 8 days. 
Splenocytes from these mice were stained with anti-CDBa-PE MAb 
and then fixed, permeabilized, and stained with anti-BrdU-FITC. After 
analysis on a FACScan, the BrdU levels in the Tg CD8j” (top), Tg CD8”’ 
(middle), and nonTg CD8”’ (bottom) subsets were determined by data 
gating. Markers were set using as a negative control anti-BrdU-stained 
splenocytes from a mouse maintained on normal drinking water, The 
BrdU staining is on a logarithmic scale; numbers on the vertical axis 
correspond to the relative number of cells in each channel, These 
data are representative of two separate experiments; similar labeling 
patterns were observed in two additional experiments using mice that 
were administered BrdU water for 6 days. 
(B) CD8’“cells steadily lose BrdU label during a 3 week chase period. 
NonTg and V85 Tg mice were thymectomized and given BrdU water 
for 8 days as described in (A), and then transferred to normal water 
striking in older than in younger mice (data not shown). 
Since Bcl-2 is known to protect against apoptosis (re- 
viewed by Akbar et al., 1993; Oltvai and Korsmeyer, 1994; 
Ntiriez et al., 1994) these data are in line with the model 
that CD8’” cells are slated for peripheral deletion. How- 
ever, when we assay for the formation of oligonucleosomal 
DNA ladders (one of the hallmarks of apoptosis) by aga- 
rose gel electrophoresis (Figure 8, bottom), CD8” cells are 
not undergoing detectable apoptosis either directly ex vivo 
(lane 1) or after 3 hr in culture without stimulation (lanes 
4 and 7). DNA fragmentation is apparent after a 20 hr 
incubation in both the CD8’” (Figure 8, bottom, lane 9) 
and CD8hi (lane 10) subsets, although the fragmentation 
appears to be more extensive in CD8’” cells. 
To obtain a more quantitative discrimination between 
live, apoptotic, and dead cells, we used a recently de- 
scribed flow cytometric assay in which cells are counter- 
stained with two DNA-binding dyes, 7-aminoactinomycin 
D (7-AAD) and Hoeschst 33342 (Ho342) (Schmid et al., 
1994). Ho342 can penetrate intact cell membranes (and 
stains fragmented DNA more intensely than intact DNA), 
while 7-AAD only enters cells that have lost their mem- 
brane integrity. Thus, it is possible to obtain clear distinc- 
tions between live (Ho342+ 7-AAD-), apoptotic (Ho342*+ 
7-AAD-), and dead cells (Ho342*+ 7-AAD+) using this 
method. After culture under various stimulation condi- 
tions, splenocytes or PBL from the Vf35 Tg mice were 
stained with these two DNA-binding dyes in combination 
with anti-CD8-phycoerythrin (PE), and analyzed by flow 
cytometry. The Tg cells maintain their CD8 phenotype dur- 
ing the timeframe of these assays, but we also confirmed 
our results by using FACS-sorted CD8’” and CD8hi cells 
(data not shown). 
The CD8’” population contained more dead cells than 
did the CD8hi subset at all timepoints tested (1, 3, 8, 10, 
and 20 hr, Figure 9; data not shown). This discrepancy 
was most pronounced at the later timepoints, confirming 
our suspicions about the relative extent of DNA fragmenta- 
tion in the two subsets as visualized by agarose gel electro- 
phoresis (compare Figure 9 with Figure 8, bottom, lanes 
9 and 10). However, the proportion of apoptotic cells in 
the CD8’” subset was never more than twice that in the 
CD8hi population (Figure 9), suggesting either that the 
CD8’O cell8 transit from the apoptotic to dead compart- 
ments unusually quickly, or that they die asynchronously 
(see Discussion). In two separate experiments, stimulation 
with plate-bound anti-VP5 increased the tendency of CD8” 
cells to die, and the addition to the cultures of exogenous 
for the indicated number of days. The percent of BrdU+ cells among 
Tg CD8’” (shaded bars), Tg CD8”’ (open bars), and nonTg CD8”’ (stip 
pled bars) cells are shown for each chase point. Data shown are repre- 
sentative of two independent experiments using one mouse of each 
type per timepoint; error bars for the day 0 timepoint indicate the range 
of values obtained from two mice analyzed in separate experiments. 
The percent of CD8” and CD8”’ cells among splenocytes collected 
from the individual mice remained relatively constant throughout the 
course of the experiment. 
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Figure 7. CD8’” Cells Are Functionally Compromised 
(A) The frequency of CTL precursors is greatly reduced among CD8” 
relative to CD8”’ cells. The frequency (9 of total CTLp was determined 
using FACS-sorted PBLs pooled from six 12- to 14-week-old V85 Tg 
mice. 
(B) CDB” cells do not proliferate well. The proliferative responses of 
CD8” and CD8”’ cells to the indicated stimuli was assessed using 
FACS-sorted splenocytes pooled from three 1 &week-old Vf35 Tg mice. 
The minus and plus symbols refer to the absence or presence of 25 
U/ml of rlL-2 in the cultures. Data shown are representative of two 
independent experiments. The fold difference in the proliferative ca- 
pacity of CD8”’ and CD8” cells is also shown, calculated as CD8”’ cpm 
incorporatedlCD8” cpm incorporated. 
(C) CD8’” cells do not flux Ca*+ as efficiently as do CD8”’ cells in re- 
sponse to signals through the TCR-CD3 complex. Calcium flux analy- 
ses were conducted using splenocytes from a 21-week-old Vf35 Tg 
mouse. The point at which 145-2Cll was added is indicated with an 
arrow. The mean indo-l violet/blue ratio is shown for CD8”’ (solid line), 
CD6 (broken dashed line), and total ungated (dashed line) spleno- 
cytes. Similar results were obtained in three separate experiments 
with both spleen and PBL from 15- to 21-week-old mice. 
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Figure 8. CD8’” Cells Express Reduced Levels of Intracellular Bcl-2 
Protein, but Are Not Apoptotic Directly Ex Vivo 
(Top) PBL from a 23-week-old Vf35 Tg mouse or a nonTg littermate 
(data not shown)were counterstained with 3Fll (anti-Bcl-2) plus FITC- 
goat anti-hamster immunoglobulin and anti-CDBa-PE. After analysis 
on a FACScan. the Bcl-2 levels in the CD8” (solid thick line) and CD8”’ 
(solid thin line) subsets were determined by data gating. The same 
cells (ungated) stained with FITC-goat anti-hamster immunoglobulin 
without 3Fll are included for comparison (dashed line). Numbers on 
the vertical axis correspond to the relative number of cells in each 
channel, normalized to the number of cells stained with second stage 
antibody alone. 
(Bottom) Splenocytes (lanes l-8, 9, and 10) or PBLs (lanes 7 and 8) 
pooled from 2 (for spleen) to 13 (for PBLs) lo- to 28-week-old Vp5 Tg 
mice were passed over nylon wool to enrich for T cells, stained with 
anti-CDB-PE, and then FACS-sorted at 4°C into CD8” (lanes 1, 4, 7, 
and 9) and CD8”’ (lanes 2, 5,8, and 10) populations. Control unsorted 
nylon wool-nonadherent cells were also analyzed (lanes 3 and 6). 
Cellular DNA was isolated from these cell populations either immedi- 
ately after sorting (lanes l-3), or 3 (lanes 4-8) or 20 hr (lanes 9 and 
10)aftercultureat37°Cwithoutstimulation. Control DNAwasobtained 
from 86 thymocytes that had been irradiated (1,200 rads) and cultured 
for 16 hr at 37% (lane 11). cultured for the same length of time without 
prior irradiation (lane 12) or freshly isolated (lane 13). Each lane repre- 
sents 2-4 x lo5 cell equivalents. 
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STIMULUS: 
6 hours 20 hours Figure 9. CDB’“Cells Die In Vitro More Readily 
than Do CDB”’ Cells 
ice 
Vlg 
+ anti-VP5 
+ anti-CD3e 
+ anti-TCRP 
CD8high 
Splenocytes from a 1 Cweek-old V65 Tg mouse 
were cultured in the absence of exogenous IL-2 
on plates precoated with the indicated antibod- 
ies. After 6 or 20 hr at 37%, the cells were 
harvested, stained with anti-CDBa-PE, Ho342, 
and 7-AAD, and analyzed on a FACStar Plus. 
Control unstimulated cells were incubated on 
ice for the same length of time. At least 200,000 
ungated events were collected and gated elec- 
tronically on each CD8 subset. The sum of the 
percent of cells falling into the apoptotic 
(shaded bars) and dead (hatched bars) com- 
% AF’OPTOTIC + % DEAD partments is plotted for each of the stimulation 
conditions. The values obtained in each exper- 
iment for cells cultured in goat anti-mouse immunoglobulincoated wells or goat anti-hamster immunoglobulin-coated wells were comparable and 
are averaged here for simplicity (lo lg). Similar results were obtained in six separate experiments using 15- to 26week-old Vf35 Tg mice. 
IL-2 did not rescue them (Figure 9; data not shown). This 
result at least partially explains why the CD8r” cells do 
not proliferate well, even in the presence of PMA plus 
ionomycin plus IL-2 (see Figure 76). 
Discussion 
We have described a mouse model system in which 
chronic deletion of mature peripheral T cells is accompa- 
nied by the emergence in the blood and spleen of a distinct 
population of small CD8+ cells that exhibit signs of prior 
activation and express low levels of many surface recep- 
tors, including the TCR-CD3 complex and its CD8 core- 
ceptor (Figures l-3). DNA isolated from these CD8’” cells 
directly out of the animal or after 3 hr of culture has not 
been cleaved between nucleosomes, as is characteristic 
of cells undergoing apoptosis (Figure 8). This contrasts 
with the prominent DNA laddering seen in MIS-la-reactive 
CD4+ cells, which have down-regulated TCRs but not core- 
ceptors(Huang and Crispe, 1993). However, unlike identi- 
cal cultures of CDBhi cells, cell death rapidly predominates 
in populations of CD8r0 cells cultured in wells coated with 
anti-TCR antibodies (Figure 9), suggesting the CD8’0 cells 
are poised to die. In fact, their small size, decreased levels 
of coreceptor expression, absence of DNA laddering, and 
rapid cell death upon culture are all properties shared by 
a recently described transient population of preapoptotic 
CD4+CD8+ thymocytes (Cohen et al., 1993). In spite of 
these parallels, we detect only a slight enrichment for 
apoptotic cells among CD8’” cells cultured for l-20 hr (Fig- 
ure 9; data not shown). Heterogeneity within the CD8’” 
subset may explain why we do not detect a large proportion 
of apoptotic cells at any single timepoint during their in 
vitro culture. If the tolerogenic signal triggering CD8 
down-regulation is delivered asynchronously to the 
population of CD8”’ T cells, the CD8” subset could be ex- 
pected to undergo apoptosis continuously rather than in 
well-defined waves. The fact that the CD8r” subset ex- 
presses heterogeneous levels of Bcl-2 supports this model 
(Figure 8). DNA laddering is apparent in CD8’” cells after 
20 hr of culture (Figure 8), indicating they do eventually 
die by apoptosis. 
The unusual tendencyofCD8r”cellstodie invitrocompli- 
cates long-term assays of cell function. Data indicating a 
profound reduction in CTLp activity and proliferative ca- 
pacity within the CD8’” population are collected after 3-7 
days in culture (Figures 7A and 78). Therefore, we mea- 
sured the ability of anti-CD3 to induce Ca*+ mobilization 
in CD8+ cells directly ex vivo, at a time when cell viability 
is not an issue (Figure 7C). Again, CD8” cells are charac- 
terized by a less robust response than their CDBhi counter- 
parts. Although CD8’” cells express reduced levels of sur- 
face TCR-CD3 complexes (Figure 3) the overall kinetics 
of the response is the same for both CD8 subsets (Figure 
7C), and the addition of higher concentrations of anti-CD3E 
MAbdoes not restore the CD8’” response (data not shown). 
These data imply that the difference in amplitude of the 
CD8’” and CD8”‘Ca*+flux curves is not solely dependent on 
TCR expression levels. An ideal experiment would involve 
stimulation through a surface molecule, such as CD2, 
whose expression is not reduced on CD8r” cells; however, 
suitable reagents directed against these molecules do not 
exist. 
Taken together, our data indicate that the TCR reper- 
toire can be continuously modulated, even in the absence 
of thymic export, by the activation-induced triggering of a 
deletional pathway. In our model system, CD8’ (but not 
CD4+) T cell deletion is characterized by the appearance 
of an intermediate population of TCR’” coreceptorr” small 
lymphocytes with a memory cell phenotype that recircu- 
late poorly from the blood to the lymph nodes, are function- 
ally compromised, and are targeted for death. 
How Do CD@” Cells Arise? 
The following three possibilities can explain the appear- 
ance of CD8r” cells. First, these cells may represent an 
outgrowth of an initially rare subpopulation that exits the 
thymus with low levels of CD8, perhaps a result of intra- 
thymic selection driven by a high avidity TCR-ligand inter- 
action (Teh et al., 1989; Jameson et al., 1994). Second, 
random down-regulation of TCR-coreceptor expression 
in the periphery may promote cell survival by decreasing 
the affinity of the interaction with the tolerogen, resulting 
in the peripheral selection of CD8” cells. Or third, the 
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down-regulation of CD8 may result from interaction with 
the tolerogen and represents the first step on a pathway 
to peripheral deletion (Rocha and von Boehmer, 1991; 
Rocha et al., 1995). It is this final possibility that is best 
supported by our data. The appearance of CD8’” cells coin- 
cides with the loss of transgene-bearing cells from the 
periphery (Figure l), and their representation among total 
CD8+ cells increases dramatically in older mice and in 
adult-thymectomized mice (Figures 1 C and 4A). The num- 
ber of Thy-l +CD4CD8- peripheral cells does not increase 
in the Tg mice relative to nonTg littermates (data not 
shown), suggesting that CD8’” cells do not leave this com- 
partment by extinguishing CD8 expression, as is the case 
in at least one other system (Schdnrich et al., 1991). In 
common with cells activated in vivo by injection of SAg 
(Lussow et al., 1993), CD8r0 cells are sensitive to hydrocor- 
tisone treatment (Figure 5) and they are functionally in- 
competent in vitro (Figure 7). Finally, CD8’” cells have re- 
duced levels of the intracellular “anti-apoptosis” protein 
Bcl-2 (Figure 8), and they die much more readily in vitro 
than do CD8”’ cells, both spontaneously and in response 
to immobilized anti-TCR-CD3 MAbs, a feature which is 
only partially reversed with the addition of exogenous IL-2 
(Figures 7 and 9). All these properties suggest CD8r0 cells 
are slated to die in vivo. Consistent with this model is the 
observation that the CD8’” compartment is extensively la- 
beled by in vivo administration of BrdU, and that this label 
is rapidly and steadily lost after BrdU withdrawal (Figure 
6). These data indicate that CD8r0 cells rapidly proliferate 
in vivo or are derived from a proliferating compartment. 
The enhanced cell death and the reduced capacity of 
CD8”‘cells to proliferate in vitro (Figures 7 and 9) favor the 
latter possibility. CDBhi cells from VP5 Tg mice incorporate 
more BrdU than those from nonTg mice (Figure 6) and 
represent a likely progenitor compartment for CD8” cells. 
More direct experiments aimed at identifying which cells 
generate the CD8’” subset have yet to be performed. 
It is of further interest that the CD8”’ pool of mature T 
cells is not exhaustively converted to the CD8’” phenotype 
(Figures 1C and 4), as nearly all the CD8+ T cells that 
remain in Vp5 Tg mice 4-5 months after thymectomy are 
CD8hiV65hi. It is possible that the remaining CD8”’ cells 
have survived because they express TCRa chains that 
preclude interaction with the tolerogen (Smith et al., 1992; 
Vacchio et al., 1993; Waanders et al., 1993; Blackman et 
al., 1993; Lussow et al., 1993). A comparison of the TCRa 
chain repertoires of CD8hi and CD8’” cells in old or thymec- 
tomized VP5 Tg mice may resolve this issue. 
What Antigen Drives the Formation of CD8” Calls 
and the Depletion of Vp5+ Cells in both CD4+ 
and CD8+ Compartments? 
Both the tolerogen-driven deletion of CD4+Vf35+ cells and 
the appearance of CD8r”V85r0 cells have been docu- 
mented in nonTg mice (Fink et al., 1994; data not shown), 
and this dependence upon the expression of a V85+ TCR 
defines the tolerogen in our system as a SAg. Several 
endogenous Mtv proviruses are known or suspected to 
influence the frequency of V85’ T cells. In adult mice that 
bear MHC class II I-E molecules, expression of a product 
encoded by the Mtv-9 provirus causes the intrathymic de- 
letion of V85+ T cells (Woodland et al., 1990, 1991 a, 
1991 b). In Mtv-9- strains of mice, the l-E-dependent dele- 
tion of V85+ T cells requires Mtvd (Gollob and Palmer, 
1992) although additional factors may be required (Foo- 
Phillips et al., 1992). However, the chronic peripheral dele- 
tion of V85+ T cells we have documented in I-E- mice re- 
quires neither Mtv-6 nor Mtv-9 (Fink et al., 1994). If the 
tolerizing SAg in our system is an Mtv, the most likely 
candidate is Mtv30, which is carried by our VP5 Tg mice 
(Finket al., 1994)and has been placed bysequenceanaly- 
sis in the family of proviruses whose products react with 
VP5 (Brandt-Carlson et al., 1993). Breeding the Vf35 Tg 
mice onto an Mtv background (Cohen et al., 1982; Ferrick 
et al., 1992) will pinpoint which, if any, Mtv proviral inte- 
grants are required to cause the observed depletion of 
Vp5 Tg cells. 
Regardless of the identity of the tolerogen, it is interest- 
ing that despite the concurrent loss of CD4+V85+ cells in 
the Tg mice (Figure 1 A), we have never observed a parallel 
population of CD4’” cells. This suggests that distinct mech- 
anisms of peripheral deletion may operate on the CD4+ 
and CD8+ T cell subpopulations, perhaps a reflection of 
the differential affinity of CD4’ versus CD8+ cells for the 
SAg-like tolerogen. Thus, it may be that CD8’cells receive 
a weaker signal than that delivered to CD4’ cells, particu- 
larly if, as for known SAgs, the tolerogen is presented by 
MHC class II. Although it is known that both CD4+ and 
CD8+ cells can respond to SAgs presented by class II (re- 
viewed by Scherer et al., 1993) the different response to 
the tolerogen by the two subsets in our system may be 
further attributable to the hierarchy of preferred class II 
molecules in the presentation of SAgs, with I-E generally 
preferred over I-A (for example see Acha-Orbea and 
Palmer, 1991). In the case of HIV-1 infection, downmodu- 
lation of CD4 can occur by a variety of different mecha- 
nisms, including transcriptional control, translational con- 
trol, and protein compartmentalization or degradation 
(reviewed by Bour et al., 1994). While the mechanisms 
of CD8 modulation are presently unclear, it is likely that 
coreceptor expression is regulated differently in CD4+ and 
CD8+ cells (Anderson and Coleclough, 1993). 
Where and When Is the Tolerogen Expressed? 
One of the most interesting features of CD8r0 cells is their 
presence in blood and spleen and their absence from pe- 
ripheral lymph nodes (Figure 2). The CD8 staining profiles 
for splenocytes are reproducibly broader than for PBL, in 
which the CD8’” subpopulation is characteristically very 
well defined and more abundant than in the spleen (Figure 
2). Furthermore, the levels of Bcl-2 expression in blood- 
derived CD8’” cells are reproducibly lower than in splenic 
CD8r” cells (data not shown). To take all these findings 
into account, we favor a model in which CD8”’ Tg cells 
encounter the tolerogen in the spleen, are activated, down- 
regulate Bcl-2 and CD8 expression (resulting in broad CD8 
staining profiles), and acquire a surface phenotype that 
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prevents them from recirculating to peripheral lymph 
nodes (Figure 3). The CD8’” cells would continue to circu- 
late from the spleen to the blood and back, and eventually 
exit the spleen for transport to an as yet undefined site for 
elimination (see below). However, examination of whether 
the antigen is preferentially expressed in a tolerogenic 
form in the spleen compared with the lymph nodes first 
requires the clear identification of the tolerogen. 
Regardless of the exact site of tolerogen encounter, it 
is evidently peripheral. Reducing or eliminating the influx 
of recent thymic emigrants that have yet to meet the tolero- 
gen results in an increase in the proportion of CD8’” cells 
in old or surgically thymectomized mice (Figures 1C and 
4A). Furthermore, the depletion of CD4+V85+ cells is accel- 
erated dramatically after thymectomy (Fink et al., 1992; 
data not shown). What then explains the gradual nature 
of the predominance of CD8’” cells (Figures 1 and 4)? Per- 
haps the decreased expression of la molecules on cells 
from mice that lack I-E (McNicholas et al., 1982) conse- 
quently limits presentation of the unknown tolerogen 
(Woodland et al., 1991 b) and decreases the chances of 
an encounter between reactive T cell and antigen-bearing 
cell. This interaction may then be of such a low affinity 
that repeated encounters with the tolerogen are required 
to drive a V85+ T cell down the tolerance pathway (Webb 
etal., 1990; Jenkins, 1992; Golloband Palmer, 1993; Ham- 
merling et al., 1993). 
Where Are the CD8” Cells Eliminated? 
Some evidence has suggested that the intestine and the 
liver are sites for elimination of antigen-activated mature T 
cells (Sprent, 1976; Webb et al., 1992; Crispe and Huang, 
1994). In one system, T cells activated by injecting TCR 
Tg mice with antigenic peptide disappear from the lymph 
nodes and spleen and accumulate in the liver, where they 
express 6220, down-regulate TCR and coreceptor expres- 
sion, and die by apoptosis (Huang et al., 1994). In VP5 Tg 
mice, CDB’O cells are not more highly represented among 
intrahepatic T cells or intraepithelial lymphocytes of the 
small intestine than among splenic Tcells or PBL, and they 
do not express 8220 (data not shown). However, given 
the probable heterogeneity within the CD8’” compartment 
(Figure 8) adoptive transfer of BrdU-labeled populations 
of CD8’” cells may be necessary to identify accurately the 
site of their elimination. 
Do CD8’” Cells Have a Specific In Vivo Function? 
Identification of an intermediate in a deletion pathway in- 
vites speculation on the potential in vivo functions for the 
CD8’” cells. These cells have the recirculation properties 
of memory cells, and would therefore be expected to enter 
inflamed tissues (Mackay, 1991). Could CD8’” cells regu- 
late immune responses at sites of inflammation by func- 
tioning as veto cells (Fink et al., 1988) or by sequestering 
antigens or cytokines (Lombardi et al., 1994)? Can CD81° 
cells help orchestrate immune responses by secreting cy- 
tokines in response to antigenic stimulation (Kemeny et 
al., 1994) given that TCR-mediated signaling in these cells 
is only somewhat diminished (Figure 7C)? One group has 
recently demonstrated that it is possible to generate mu- 
rine CD8’ CTL clones (analogous to CD4+ T helper 2 
clones) that secrete IL-4, IL-5 11-6, and IL-10 (Sad et al., 
1995), and some of these so-called TC2 clones appear to 
express low levels of CD8. Cytokine production by the 
CD8’O cells we have identified in Vf35 Tg mice remains to 
be investigated. Finally, it is possible that CD8” cells serve 
as a reservoir of cells rescuable under the appropriate 
conditions of antigenic stimulation. While reversal of the 
down-regulation of TCR or coreceptor expression in other 
systems has been inferred (Huang and Crispe, 1993) or 
demonstrated (Schbnrich et al., 1991), we do not yet know 
whether CD8” cells can reexpress high levels of TCR and 
coreceptor. Since CD8“’ cells express low levels (data not 
shown) of the costimulator molecule CD28 (reviewed by 
June et al., 1994), drawing them back into the pool of 
functional T cells could require more than up-regulation 
of TCR and coreceptor molecules. 
Concluding Remarks 
The chronic modulation of the peripheral T cell repertoire 
we have described here probably also occurs in unmanipu- 
lated mice bearing diverse TCRs, either in the course of 
normal immune responses or in response to weakly stimu- 
lating self-antigens. This postulate is supported by the 
identification of both CD8’0V8510 and CD8hiV85hi cells in 
nonTg littermates of VP5 Tg mice (data not shown) and 
of CD8’” cells in mice responding to lymphocytic chorio- 
meningitis virus (Razvi et al., 1995). The V85 Tg model 
system is unique by virtue of the fact that the outcome of 
peripheral tolerance within the CD4+ T cell subset is dis- 
tinct from that in the CD8+ population, perhaps a reflection 
of the nature of the tolerogen. A second advantage of our 
system is that only a fraction of T cells is susceptible to 
tolerance induction, resulting in the coexistence in vivo 
of phenotypically distinct tolerized CD81° cells with their 
immunocompetent CDBhi counterparts. Further analysis 
of this model system should improve our understanding 
of the processes that nudge cells one way or the other 
along the multistep pathway leading from responsive na- 
ive T cells to apoptotic cells destined for elimination. 
Experimental Procedures 
Mice and Surgical Procedures 
B6 TCRf3 chain Tg mice (H-2K”, I-E-) were constructed by injection of 
a rearranged genomic Vf35.2+ 5 chain gene from a CD6+ CTL clone 
specific for chicken ovalbumin (OVA) and H-2Kb, and have been 
previously described (Fink et al., 1992; Carbone et al., 1992). 
(B6xBXD15)Fl Vf35’Tg mice carry the proviral integrants Mtv-1, Mtv-6, 
Mtv-6, Mtv-9, Mtv-1 1, Mtv-13, Mtv-17, and Mtv-30 and were the result 
of crossesof the B6Tg mice(Mtv-6+Mtv-9+Mtv-l7+Mtv-30+) with BXDIS 
(Mtv-l+Mtv-G+Mt@+Mtv-1 l+Mtv-13+Mtv-17+Mtv-30’) an H-2b (I-E-) re- 
combinant inbred line derived by Dr. B. Taylor from 86 and DBA/2 
parent lines and purchased from The Jackson Laboratory (Bar Harbor, 
Maine). NonTg mice were offspring from these same matings. B6 mice 
were also purchased from The Jackson Laboratory. For cortisone treat- 
ment, hydrocortisone Pl-acetate (Sigma Chemical Company, St. 
Louis, Missouri) was dissolved in a small volume of 1000% ethanol and 
then brought to 25 mglml in Hanks balanced salt solution. Each mouse 
was injected intraperitoneally with 5 mg of the colloidal suspension; 
PBL, spleens, or both from injected and uninjected control mice were 
isolated for analysis 2 days later. For BrdU incorporation studies, mice 
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were given drinking water containing BrdU (Sigma) at 0.8 mg/ml, which 
was made fresh and changed daily. For pulse-chase experiments, 
mice were given BrdU water for 8 days and then transferred to normal 
drinking water. Thymectomies were performed on mice under tribro- 
moethanol anesthesia; thymuses were removed by suction and 
wounds were closed by suture. Unless otherwise noted, PBL were 
isolated from whole heparinized blood by water lysis, and lymph node 
cells were derived from pooled axillary, brachial. inguinal, cervical, 
and mesenteric nodes. 
Reagents 
PE-conjugated anti-CD8a (clone 53-6.7, rat [r]lgGPa) and anti-CD4 
(clone RM-4-5, rlgG2b) antibodies, biotinylated anti-CD44/Pgp-1 
(clone IM7, rlgGPb), anti-CD2 (clone RM2-5, rIgGab), and antiCD3s 
(clone 500 A2, hamster immunoglobulin G [hlgG])antibodies, and puri- 
fied anti-Bcl-2 (clone 3F11, hlgG) antibody were all purchased from 
PharMingen (San Diego, California). FlTCconjugated anti-Thy-l .2 
(clone TS, mlgM) antibody was purchased from ICN (Lisle, Illinois); 
FITC-conjugated anti-BrdU MAb (clone 844, mlgG1) was purchased 
from Becton Dickinson (Mountain View, California). MR9-4, a murine 
IgGl antibody specific for V85.1+5.2 (Kanagawa et al., 1991) PS12, 
a rlgG2b antibody specific for murine CD49d (VLA-4) (Miyake et al., 
1991) EH144, a murineantibodyspecificfor H-2Kb(Geieret al., 1986). 
and MEL-14, a rlgG2a antibody specific for CD62L, the murine periph- 
eral lymph node homing receptor (Gallatin et al., 1983) were purified 
from ascites or tissue culture supernatants over protein A or G col- 
umns. Antibodies were conjugated with biotin or FITC according to 
established protocols (Harlow and Lane, 1988). FITC-, PE-, and tri- 
color-conjugated streptavidin, purified goat anti-mouse immunglobulin 
and goat anti-hamster immunoglobuin (purified and FITC-conjugated), 
and FITC-conjugated goat anti-rat IgG were purchased from Caltag 
(San Francisco, California). FlTC-conjugated goat anti-mouse IgG Fc 
was purchased from Cappel (Malvern, Pennsylvania). The hamster 
IgG antibody 145-2Cll (Leo et al., 1987) specific for murine CD3s, 
and H57-597, a hamster IgG antibody specific for the murine TCR8 
chain (Kubo et al., 1989) were used as culture supernatants for cell 
proliferation; purified 145-2011 used in calcium flux assays was a 
gift from Dr. R. Perlmutter. FITC-conjugated antiCD45RB (clone 16A, 
rlgG2a. Johnson et al., 1989) was a gift from Dr. A. Rudensky. Anti- 
CD1 1 a (clone KBA, rlgGPa, Nishimura et al., 1985) ascites and FITC- 
anti-CD54 (clone YN111.7, rlgGPa, Takei, 1985) were both gifts from 
Dr. E. Clark. 
Cell Staining and Flow Cytometry 
Cells were stained as described previously (Fink et al., 1992) and 
analyzed on a FACScan (Becton Dickinson) using LYSYS II or Consort 
30 software. Unless otherwise noted, dead cells were excluded on the 
basis of forward and side scatter profiles. A minimum of 10’ events 
were analyzed for each sample. Sterile cell sorting, calcium flux analy- 
ses, and apoptosis assays utilized a FACStar Plus (Becton Dickinson) 
with LYSYS II software. Staining for intracellular Bcl-2 protein was 
performed as described (Veis et al., 1993) by permeabilizing cells 
with saponin detergent (0.03% in PBS plus l%BSA), staining with 
anti-Bcl-2 MAb followed (after a wash) by FITC-conjugated goat anti- 
hamster IgG, then counterstaining with anti-CDB-PE in PBSlBSA with- 
out saponin. For BrdU incorporation studies, cells from BrdU-labeled 
mice (or unlabeled control mice) were surface stained with anti-CDB- 
PE and then fixed, permeabilized, and counterstained with FITC-anti- 
BrdU MAb as described previously (Tough and Sprent. 1994). After 
analysis on a FACScan, the Bcl-2 or BrdU levels in each CD8’ subset 
were determined by electronic gating. 
Functional Assays 
To determine CTL precursor frequencies, PBL pooled from V85 Tg 
mice were passed over nylon wool columns to enrich for T cells, stained 
with anti-CD8-PE, and sorted into CD8” and CD8”‘populations. Sorted 
cells were plated in 60-84 wells per dilution with 2 Kg/ml concanavalin 
A (ConA) and 5 x lo5 irradiated syngeneic spleen cells as feeders in 
thepresenceof lO%ratConAsupernatant.CTLactivitywasmeasured 
7 days later using S’Cr-labeled syngeneic EL4 (B6-derived thymoma) 
target cells in the presence of the lectin phytohemagglutinin-P (Difco 
Laboratories, Detroit, Michigan) as a glue (Bevan and Cohn, 1975; 
Wilson et al., 1982). Positive wells were defined as those in which 
the amount of released “Cr exceeded by 3 SD that released in wells 
containing stimulators alone. The dilution of cells is plotted versus the 
log of the fraction of negative wells at that dilution, with precursor 
frequencies defined as the inverse of the x intercept where y = 0.37 
(Taswell, 1981). For proliferation assays, Vj35 Tg splenocytes were 
passed over nylon wool columns, treated with anti-CD4 MAb (RL172) 
and guinea pig complement (BRL, Bethesda, Maryland), stained with 
anti-CDB-PE, and sorted into CD8M and CD8”’ populations. Some 
sorted cells were cultured in triplicate at 2 x 10’ per well plus 5 x 
lo5 nonTg 3000 rad irradiated spleen filler cells in the presence of 
2 Kg/ml ConA or in wells precoated with either goat anti-mouse immu- 
noglobulin plusor minus anti-V85 or goat anti-hamster immunoglobulin 
plus or minus anti-CD3s. The remainder were cultured at 2 x IO4 per 
well in the absence of filler cells with 500 &ml ionomycin (Calbio- 
them, San Diego, California) or 2 r&ml PMA (Sigma Chemical Com- 
pany, St. Louis, Missouri) or both. Where indicated, medium contained 
25 U/ml recombinant human 11-2, provided by CetusCorporation (Em- 
eryville, California; Wang et al., 1984). Wells were pulsed with 
13H]thymidine on day 2 and harvested on day 3 af culture. The data 
from triplicate wells were averaged together and background prolifera- 
tion (in the absence of specific antibody or ConA) was subtracted. 
Background counts were always less than 1700 cpm. 
Calcium Flux Assays 
Flow cytometry, indo-l loading, and analysis of Ca2+ data were per- 
formed essentially as described (Rabinovitch et al., 1986; Cooke et 
al., 1991). In brief, single cell suspensions of splenocytes depleted of 
red blood cells by Ficoll gradient centrifugation were brought to a 
concentration of lO’/ml and incubated with 1 uM indo-l (Molecular 
Probes, Eugene, Oregon) for 30 min at 37OC. Cells were washed twice 
and resuspended in media containing azide-free anti-CD8u antibody 
for 30 min at room temperature and washed again. Baseline CaZ+ levels 
were established for 1 min prior to adding stimulatory antibody; data 
were collected for a total of 7.5 min. Cells were stimulated directly 
with 50 ug/ml 145-2Cll. Analysis of cell subsets was achieved by 
gating electronically on either CD8” or CD8”’ populations; data were 
analyzed using MTIME software as described (Rabinovitch et al., 
1986). 
Detection of Apoptosfs 
To isolate cellular DNA for visualization on agarose gels, cells were 
washed, dissolved in hypotonic lysing buffer (100 mM NaCI, 10 mM 
Tris, 1 mM EDTA, 1% SDS, 200 pglml proteinase K [pH 7.51). and 
incubated for 45 min at 50°C. DNA was isolated as described (Nicoletti 
et al., 1991) electrophoresed on a 1% agarose gel, and visualized 
by ethidium bromide staining. To obtain a more quantitative measure 
of apoptosis and death, V85 Tg splenocytes or PBLs were depleted 
of red blood cells by Ficoll gradient centrifugation and cultured at 
5 x 10Scells/well in a flat-bottomed 96well plate precoated with goat 
anti-mouse immunoglobulin plus or minus anti-V85 or goat anti- 
hamster immunoglobulin plus or minus anti-CD3s or anti-TCR8. After 
incubation, the cells were harvested and stained with anti-CD8-PE 
and two DNA-binding dyes, Ho342 and 7-AAD. both purchased from 
Molecular Probes (Eugene, Oregon), and analyzed on a FACStar Plus 
using logarithmic amplifiers for each fluorescence channel, as de- 
scribed (Schmid et al., 1994). By gating electronically on each of the 
CD8 subsets (which maintain their CD8 phenotype in culture), this 
method allows a quantitative discrimination within each population 
between live cells (Ho342+ 7-AAD-), dead cells (Ho342” 7AAD+), and 
those undergoing apoptosis (Ho342*+ 7-AAD-). To control for the effi- 
ciency of uptake of 7-AAD and Ho342 by dead cells in each experiment, 
2 x 1 On spleen cells were incubated at 80°C for 1 O-l 5 min and stained 
in parallel. These controls were consistently 90%-100% H0342~’ 
7-AAD’. 
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